Total | No cancer | Cancer | P value | |
---|---|---|---|---|
N, 77 | N, 48 (62.3%) | N, 29 (37.7%) | – | |
Age, yr | 68.0 (12.0) | 66.5 (11.0) | 71.0 (12.0) | 0.010 |
tPSA, ng/mL | 6.41 (2.5) | 6.42 (2.3) | 6.13 (2.8) | 0.877 |
fPSA | 0.92 (0.5) | 0.97 (0.6) | 0.92 (2.4) | 0.185 |
%fPSA | 15.49 (8.6) | 16.83 (7.5) | 13.04 (7.1) | 0.284 |
p2PSA, pg/mL | 16.86 (17.5) | 15.34 (16.1) | 17.09 (23.7) | 0.189 |
%p2PSA | 1.61 ( 1.6) | 1.50 (1.0) | 2.35 (2.6) | 0.015 |
PHI | 41.35 (37.9) | 39.65 (28.9) | 53.72 (56.8) | 0.018 |
Positive core number | – | – | 4.0 (7.0) | – |
Number (percentage) | ||||
GS 6 | – | – | 9 (31%) | – |
GS 7 | 10 (34.5%) | – | ||
GS ≥ 8 | 10 (34.5%) | – |